Search Results
Jan 27, 2026, 10:01 ET Proteomics Market worth $65.78 Billion by 2030 | MarketsandMarkets™
through robust protein identification and quantification methods. The spectroscopy sub-market is segmented into mass spectroscopy, NMR spectroscopy, and CD spectroscopy.Request Sample Pages@
More news about: MarketsandMarkets
Jan 27, 2026, 08:00 ET BrowserStack Launches Accessibility DevTools to Shift Left Accessibility Testing into IDE
integrated with tools like Copilot, Claude, and Cursor, for faster, context-aware fixes.Accessibility enforcement in Git pre-commit hooks and CI/CD builds via CLI tool, preventing inaccessible code from reaching production.Lint accessibility issues in custom internal components, and not
More news about: BrowserStack
Jan 27, 2026, 08:00 ET BrowserStack Launches Accessibility DevTools to Shift Left Accessibility Testing into IDE
integrated with tools like Copilot, Claude, and Cursor, for faster, context-aware fixes.Accessibility enforcement in Git pre-commit hooks and CI/CD builds via CLI tool, preventing inaccessible code from reaching production.Lint accessibility issues in custom internal components, and not
More news about: BrowserStack
Jan 27, 2026, 08:00 ET Gluware Named Finalist in Two Categories of SiliconANGLE Media's 2026 Tech Innovation CUBEd Awards
manage powerful automations up to 100x faster using the open-source scripts they already rely on. The platform combines advanced tooling – including CI/CD integrations, Visual Studio Code extensions, native Git support with GitHub and Bitbucket, and AI-powered Co-Pilots – with Gluware DIAL, which supports
More news about: Gluware Inc
Jan 26, 2026, 19:00 ET Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
more prior lines of therapy, including exposure to PIs, IMiDs, and anti-CD38 antibodies, treatment options include, but are not limited to, BCMA-targeted CAR-T therapies and bispecific antibodies targeting CD3×BCMA or CD3×GPRC5D. However, the benefits of these approaches may be limited by antigen loss
More news about: Innovent Biologics
Jan 26, 2026, 08:00 ET Axcelis Announces Timing and Availability of Fourth Quarter and Full Year 2025 Results and Conference Call
https://register-conf.media-server.com/register/BIfd551cd8408c4503b0229e94192ef512Webcast replays will be available for 30 days following the call.About Axcelis:Axcelis
More news about: Axcelis Technologies, Inc.
Jan 26, 2026, 08:00 ET MainStreet Bancshares Inc. Reports a Profitable 2025 and remains focused on serving the Washington, DC Metropolitan Community
(2)Consists of certificates of deposit (CD) through multiple listing services and multiple brokered deposit services, as well as ICS and CDARS one-way certificates of deposit and regional money
More news about: MainStreet Bancshares, Inc.
Jan 23, 2026, 13:43 ET What's New in the Liquid CD Market as 2026 Begins? CD Valet Releases No‑Penalty CD Rate Roundup in an Ambiguous Market
real-time CD insights and tools into one place, our digital CD marketplace helps consumers act decisively when conditions change – while enabling financial institutions to stay visible to rate-sensitive consumers in a fast-shifting environment."About CD Valet CD Valet is a CD marketplace
More news about: CD Valet
Jan 23, 2026, 09:24 ET PROCOMER and essential COSTA RICA showcased the best of Costa Rican coffee at World of Coffee Dubai 2026
farms.Photo - https://mma.prnewswire.com/media/2867807/W0CD_2026.jpg
More news about: PROCOMER
Jan 23, 2026, 07:00 ET ECARX to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
https://register-conf.media-server.com/register/BI77be73bf981b49c7bed9cd333bdda80e to receive the conference call details as well as international access numbers.Please join at least
More news about: ECARX Holdings Inc.
Jan 23, 2026, 06:17 ET Navia Markets Launches 'Navia Backup', an Independent Emergency Trading Safety Net
limits. Navia Markets Ltd. SEBI Registration No.: INZ000095034 NSE Member Code (CM, FAO & CD): 07708 BSE Clearing No. (CM, FAO & CD): 6341 MCX Member ID: 45345 NSDL DP ID: IN300378 CDSL DP ID: 12086500 SEBI Registration
More news about: Navia Markets Ltd.
Jan 23, 2026, 01:07 ET Antlara Dental introduces its in-house laboratory
Info:Address: Hanover Square, London W1STelephone: +44 7770 537 469Antalya Clinic:Zümrütova, Sinanoğlu Cd. No:53A,Muratpasa/Antalya, TurkeyTelephone: +90 (541) 120 42 08Email:
More news about: Antlara Dental
Jan 22, 2026, 23:40 ET 晶泰科技賦能萊芒生物取得細胞療法重大成果，以1‰劑量CAR-T實現多位系統性紅斑狼瘡完全緩解出院
床雙重突破在晶泰科技的助力下，萊芒生物開發的代謝增強型 CD19 CAR-T療法，在自免性疾病和血液瘤領域展現出突破性治療潛力。2025 年，萊芒生物啟動了針對系統性紅斑狼瘡（SLE）的 IIT 臨床研究，取得重要進展。該療法以僅為常規 CAR-T 治療劑量千分之一（1‰）的極低劑量，在無需清淋預處理、無需中斷原有免疫抑製藥物、且住院時間顯著縮短的條件下，成功使多例中重度 SLE 患者實現無藥物依賴的完全緩解（100% CR）。基於良好的安全性數據，代謝增強型 CD19 CAR-T 療法有望支持門診式給藥模式，為自身免疫性疾病提供一種更便捷、更安全的
More news about: 晶泰科技
Jan 22, 2026, 20:39 ET Columbus McKinnon Announces Syndication and Pricing of Senior Secured Term Loan B Facility
principal amount of senior secured notes due 2033, (ii) the sale of Series A Cumulative Convertible Participating Preferred Shares of the Company to CD&R XII Keystone Holdings, L.P., and (iii) new revolving facility with aggregate commitments of $500.0 million, to finance the Acquisition (including
More news about: Columbus McKinnon Corporation
Jan 22, 2026, 19:42 ET Columbus McKinnon Announces Pricing of Senior Secured Notes
offering of the Notes, together with the proceeds from the sale of Series A Cumulative Convertible Participating Preferred Shares of the Company to CD&R XII Keystone Holdings, L.P. and the New Credit Agreement (as defined below), to finance the Acquisition (including the repayment of Kito Crosby's
More news about: Columbus McKinnon Corporation
Jan 22, 2026, 10:22 ET Florida Cancer Specialists & Research Institute Among First in Florida to Trial Next-Generation Immunotherapy for Castration-Resistant Prostate Cancer
therapies." Pasritamig brings a patient's T‑cells directly to prostate cancer cells by binding both the cancer cell protein KLK2 and the T‑cell receptor CD3, allowing the T‑cells to attack and kill the cancer. To learn more about the new phase 3 trial:
More news about: Florida Cancer Specialists & Research Institute
Jan 22, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy including an anti-CD20 containing regimen." Atara said that "[t]he CRL indicates that the FDA is unable to approve the EBVALLO™ BLA in its present form" because, according
More news about: Pomerantz LLP
Jan 22, 2026, 09:00 ET Sony Electronics Announces Crystal LED S Series, a Significant Mid-Market Addition to the Direct View LED Display Family
ZRD-S15G, feature 800 cd/m2 of maximum brightness and a 1.25 and 1.56 mm pixel pitch, respectively. These scalable displays, planned to be available in late spring 2026,
More news about: SONY ELECTRONICS
Jan 22, 2026, 07:30 ET STL completes successful trial of Multi-Core Fibre (MCF) with Colt in the UK, powering next-gen optical connectivity
line rate was achieved with validation performed for 100GE and 400GE services. Comprehensive testing was carried out, including Chromatic Dispersion (CD), Polarization Mode Dispersion (PMD), Crosstalk, Throughput, Fault analysis, OTDR, Loss, and Optical Return Loss (ORL) measurements, all of which delivered
More news about: Sterlite Technologies Ltd - STL
Jan 21, 2026, 16:25 ET FSK Announces Earnings Release and Conference Call Schedule for Fourth Quarter and Full Year 2025
https://register-conf.media-server.com/register/BI39e404f22c094c9aa787cd75ff19a5f6. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference
More news about: Future Standard
Jan 21, 2026, 09:00 ET Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Patients Receiving a Liver Transplant
and blocks CD28-mediated effector-T cell costimulation, without blocking CTLA-4, an important protein found on T cells that naturally helps keep the body's immune responses in check. VEL-101 is, therefore, expected to have a dual mechanism of action where in a direct manner, it blocks CD28-mediated T
More news about: Veloxis Pharmaceuticals
Jan 21, 2026, 09:00 ET Pentera Discovers Exposed Cloud Training Applications Actively Exploited with Crypto-Miners
their access in several ways, including lateral movement across cloud resources, privilege escalation through over-permissive roles, tampering with CI/CD workloads, or inserting themselves into software supply chain processes.The complete investigation, including findings, methodology, and evidence
More news about: Pentera
Jan 21, 2026, 07:35 ET Orion Innovation in der Analystenbewertung „Connected Product Engineering Services, Q4 2025" ausgezeichnet
Innovation. „Wir helfen unseren Kunden dabei, ihre Strategie in die Tat umzusetzen – indem wir zuverlässige Produkte entwickeln, die Markteinführung mit CI/CD und Automatisierung beschleunigen und die Leistung durch weltweiten Support während des gesamten Lebenszyklus aufrechterhalten."Orion liefert
More news about: Orion Innovation
Jan 21, 2026, 05:43 ET Orion Innovation es reconocida en Servicios de ingeniería de productos conectados, evaluación de analistas del cuarto trimestre de 2025
Innovation. "Ayudamos a los clientes a traducir la estrategia en productos confiables de ingeniería de ejecución, con lo que acelera los lanzamientos con CI/CD (Integración Continua/Entrega Continua) y automatización, y mantiene el rendimiento mediante el soporte del ciclo de vida a escala mundial".Orion
More news about: Orion Innovation
Jan 21, 2026, 00:37 ET Halper Sadeh LLC Encourages SEE, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights
Sealed Air Corporation (NYSE: SEE)'s sale to funds affiliated with CD&R for $42.15 in cash per share. If you are a Sealed Air shareholder,
More news about: Halper Sadeh LLP